As medical groups and health systems pursue performance improvement in the wake of COVID-19, provider and executive compensation must be reevaluated to optimize operations and financial performance going forward. The pandemic has skewed benchmarks for compensation and productivity, so executing a compensation program is more difficult than in years past. Not only are groups struggling with how to succeed in value-based contracts as they move away from fee-for-service arrangements, other considerations include new E/M coding policies and determining fair market value (FMV).